Alzheimer's Awareness Month: Sunrise Senior Living Offers Suggestions for Relating to Loved Ones Living with Alzheimer's Disease or Dementia.
MCLEAN, Va., Nov. 20 /PRNewswire-FirstCall/ -- The diagnosis of Alzheimer's disease in a family member or loved one can sometimes wreak havoc on these important personal relationships both emotionally and physically. While their most significant memories are slipping away, so is their ability to communicate their need for additional...

Paratonia in patients: a clinical marker of Alzheimer's disease?
SAN DIEGO -- The presence of paratonia in patients with Alzheimer's disease may be a sign of cognitive decline, according to the results of a small study. "Paratonia may be useful as a way of looking at the progression of Alzheimer's disease, because it can be seen,...

New Alzheimer's disease vaccine proven effective in mice.
Japanese researchers have developed an experimental vaccine to treat Alzheimer's disease. The DNA-based vaccine has been shown to be effective in mice, reducing brain deposits that are believed to cause the disorder. This breakthrough is considered to be the first step in bringing an effective treatment to individuals with...

Researchers at Children's Hospital Boston Say New Pathway in the Brain Could Point to Causes of Alzheimer's Disease, Schizophrenia.
SciTech21-5 October 2006-Researchers at Children's Hospital Boston Say New Pathway in the Brain Could Point to Causes of Alzheimer's Disease, Schizophrenia(C)2006 JeraOne - http://www.jeraone.com Researchers in the Neurobiology Program at Children's Hospital Boston have discovered a new molecular pathway that influences the timing of nerve-cell production, a...

Grief reactions and depression in caregivers of individuals with Alzheimer's Disease: results from a pilot study in an urban setting.
Caregivers of individuals with Alzheimer's disease are at an increased risk of mental and physical problems as a result of the strain that accompanies this role (Haley, Levine, Brown, Berry, & Hughes, 1987; Lorensini & Bates, 1997). Although literature has focused on the stress, sense of burden, and depression...

Paratonia: a clinical marker of Alzheimer's disease progression?
SAN DIEGO -- The presence of paratonia in patients with Alzheimer's disease may be sign of cognitive decline, according to the results of a small study. Paratonia (increased tone from variable resistance to movement) "may be useful as a way of looking at the progression of Alzheimer's...

Alzheimer's disease.
Five drugs are approved to treat Alzheimer's disease, but none provides a cure. Four of the five drugs are cholinesterase inhibitors, which enhance cholinergic neurotransmission and may benefit patients with mild to moderate disease. Tacrine, the first drug available in this class, is rarely used today because...

DRL, Novartis smoke peace pipe on Alzheimer's drug.
HYDERABAD: Dr Reddy's Laboratories (DRL) has entered a settlement agreement with Novartis Pharma to suspend the launch of its generic capsule rivastigmine tartrate till 2014. The rivastigmine tartrate capsule is the generic version of Novartis product, Exelon, indicated for the treatment of mild-to-moderate Alzheimer's disease dementia. It...

Stanford Study Reveals Social Networking Concepts Used in Alzheimer's Research.
HEALTH AND BEAUTY CLOSE-UP-29 June 2008-Stanford Study Reveals Social Networking Concepts Used in Alzheimer's Research(C)2008 - CloseUpMedia - newsdesk@closeupmedia.com Researchers at the Stanford University School of Medicine used concepts borrowed from the social networking site to analyze the brains of people with Alzheimer's disease. They...

Survival longer in Alzheimer's patients who took vitamin E.
CHICAGO -- Vitamin E supplementation at doses of 2,000 IU/day appeared to be associated with improved survival in a retrospective case analysis of patients who had Alzheimer's disease. The results, which were presented at the annual meeting of the American Academy of Neurology, were seen in a...